Published 1 day ago • loading... • Updated 20 hours ago

Combining protein therapy and focused ultrasound therapy can improve cancer treatment

Summary by Medical Xpress

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) with focused ultrasound (FUS) can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice University and Vanderbilt University.

2 Articles

All

Left

Center

Right

BIOENGINEER.ORG

Rice University Study Reveals Enhanced Cancer Treatment Through Focused

An innovative approach to cancer treatment has emerged from collaborative research conducted at Rice University and Vanderbilt University, focusing on a potent combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) therapy and low-intensity focused ultrasound (FUS). This groundbreaking study, recently published in the journal Advanced Science, presents compelling evidence that merging these two modalities can significantl…

20 hours ago

Read Full Article